James Emily R, Miranda Roberto N, Turner Suzanne D
Department of Pathology, University of Cambridge, Cambridge, UK.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
JPRAS Open. 2022 Feb 20;32:127-143. doi: 10.1016/j.jpra.2022.01.004. eCollection 2022 Jun.
Lymphomas of the breast are rare neoplasms that arise from breast lymphoid tissue and are characterised by neoplastic B or T cells. Breast lymphomas arising from B cells include, but are not limited to, diffuse large B cell lymphoma, follicular lymphoma, extra-nodal marginal zone lymphoma and Burkitt lymphoma. Anaplastic large cell lymphoma (ALCL) is of a T cell origin and both anaplastic lymphoma kinase (ALK)-positive and ALK-negative presentations have been noted in the breast. In addition, there is a more recently identified presentation of ALK-negative ALCL that arises around textured breast implants and is usually confined to a periprosthetic fibrous capsule. Here, we discuss the clinical presentations, histological and immunohistochemical features and treatment options for each type of primary breast lymphoma. We hope that this review will highlight the importance of the timely and accurate diagnosis of breast lymphoma in order to tailor the most appropriate treatment. We also wish to raise awareness of the breast implant-associated lymphomas, with the goal of stimulating work that will aid our understanding of their epidemiology and pathogenesis.
乳腺淋巴瘤是起源于乳腺淋巴组织的罕见肿瘤,其特征为肿瘤性B细胞或T细胞。起源于B细胞的乳腺淋巴瘤包括但不限于弥漫性大B细胞淋巴瘤、滤泡性淋巴瘤、结外边缘区淋巴瘤和伯基特淋巴瘤。间变性大细胞淋巴瘤(ALCL)起源于T细胞,乳腺中已发现间变性淋巴瘤激酶(ALK)阳性和ALK阴性两种表现形式。此外,最近还发现一种ALK阴性的ALCL出现在有纹理的乳房植入物周围,通常局限于假体周围纤维包膜内。在此,我们讨论每种原发性乳腺淋巴瘤的临床表现、组织学和免疫组化特征以及治疗方案。我们希望这篇综述能突出及时、准确诊断乳腺淋巴瘤对于制定最合适治疗方案的重要性。我们还希望提高对乳房植入物相关淋巴瘤的认识,目的是推动有助于我们了解其流行病学和发病机制的研究工作。